RNA Therapeutics: How Far Have We Gone?
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-19966-1_7
Reference311 articles.
1. Bennett CF, Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50:259–293
2. Godfrey C et al (2017) Delivery is key: lessons learnt from developing splice-switching antisense therapies. EMBO Mol Med 9(5):545–557
3. McClorey G, Wood MJ (2015) An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. Curr Opin Pharmacol 24:52–58
4. Rossor AM, Reilly MM, Sleigh JN (2018) Antisense oligonucleotides and other genetic therapies made simple. Pract Neurol 18(2):126–131
5. Bauman JA et al (2010) Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Res 38(22):8348–8356
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ethical implications of developing RNA-based therapies for cardiovascular disorders;Frontiers in Bioengineering and Biotechnology;2024-03-15
2. The current perspective and opportunities of small nucleic acid‐based therapeutics;Drug Development Research;2024-02-27
3. Advanced Targeting Systems for Tissue-Specific Drug Delivery;Interdisciplinary Cancer Research;2024
4. Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma;Current Medicinal Chemistry;2023-11-28
5. Development of Engineered-U1 snRNA Therapies: Current Status;International Journal of Molecular Sciences;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3